Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


To better understand the impact of the pandemic on medication for opioid use disorder (MOUD) services in the U.S.

Scoping review | 2023
Substitution/OAT, Policy/Regulatory

This qualitative narrative synthesis sought to identify pathways connecting socioeconomic marginalization (SEM) and overdose for people who use drugs.

Lit review | 2023
Overdose, Poverty, Housing, Equity, Justice system/law enforcement, About PWUD

Unregulated drug markets lead to samples with unexpected and variable contents. A retrospective data analysis of Zurich's DCS was performed to determine the nature of these samples.

Original research | 2023
Drug checking

We conducted this study to understand the rural context and factors that affected access of TiOAT programs.

Original research | 2023
Rural/remote, Injecting drugs, Small/medium cities, Substitution/OAT, Barriers and enablers

We conducted an environmental scan to provide an overview of current organizational practices and characteristics of withdrawal management services (WMS) in Canadian substance use treatment systems

Original research | 2022
Cours de formation | 2023
la surdose, le stigmate social

We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to ad

Original research | 2023
About PWUD, Stigma

A clinical trial of a new OAT, depot buprenorphine provided the opportunity to obtain health and correctional staff perspectives regarding this treatment prior to widespread roll-out.

Original research | 2023
Substitution/OAT, Justice system/law enforcement, About prescribers

This study sought to understand how adaptations in the complex system of OAT provision impacted and responded to risk environments of people receiving OAT during the COVID-19 pandemic.

Original research | 2023
Substitution/OAT, About PWUD, About prescribers, Stigma
Commentary | 2023
Policy/Regulatory, Substitution/OAT, About prescribers, Carries/take-home doses

This mixed method, exploratory study utilized data from a larger study comprised of formerly incarcerated men (n = 57) and their selected social support partners (n = 57) to identify

Original research | 2023
About PWUD, Justice system/law enforcement, Social services, Parents/caregivers

The present study explores the processes through which take-home iOAT doses improved clients’ quality of life and continuity of care in real-life settings.

Original research | 2023
Safer supply, About PWUD, Injecting drugs, Social benefits

Patients with opioid use disorder (OUD) frequently leave the hospital as patient directed discharges (PDDs) because of untreated withdrawal and pain.

Original research | 2023
Safer supply, Substitution/OAT, Hospitals, Outcomes

This review provides an overview of recent literature on the nature of recently published digital interventions for young people in terms of technologies used, substances targeted, intended outcome

Lit review | 2023
Digital health, Youth

This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada.

Original research | 2022
Barriers and enablers, About PWUD, Justice system/law enforcement

The current study utilized the socio-ecological model (SEM) to examine the synergistic impact of individual, interpersonal, community, and organizational/policy-level factors on reintegration exper

Original research | 2022
Justice system/law enforcement, About PWUD, Substitution/OAT

This study aimed to assess the impact of direct-acting antiviral (DAA) treatment success on quality of life (QoL) for people who inject drugs (PWID).

Original research | 2023
About PWUD, Injecting drugs, Wrap-around services, Outcomes

To quantify the association between opioid agonist treatment (OAT) and overdose death by age group; test the hypothesis that across different age groups, opioid overdose mortality is lowest during

Original research | 2023
Overdose, Mortality, About PWUD, Substitution/OAT

Substance use disorders (SUD) are prevalent among justice-involved youth (JIY) and are a robust predictor of re-offending. Only a fraction of JIY with substance use problems receive treatment.

Original research | 2023
Outcomes, Justice system/law enforcement, Youth, Transitions in care/treatment
Manuel | 2023
le stigmate social, à propos des prescripteurs, les services sociaux, la politique / le cadre de réglementation, les obstacles et les facilitateurs, les guides de pratique clinique

Refine Your Search